Effect of alpha-lipoic acid and Silybum marianum supplementation with a Mediterranean diet on metabolic dysfunction-associated steatosis

Table 4 Somatometric characteristics at baseline and weeks 12 and 24 in the control group with metabolic dysfunction-associated steatotic liver disease

Placebo + MD	Baseline	12 weeks	24 weeks	P value
Somatometry
Weight in kg	82.1 + 14.1	79.3 + 12.6	79.2 + 13.3	0.165
∆weight	-	-1.6 + 3.7	-1.0 + 4.6	0.206
BMI	33.3 + 4.7	32.1 + 4.3	32.2 + 5.0	0.16
Visceral fat as %	11.8 + 2.9	12.1 + 2.9	12.8 + 4.3	0.341
∆visceral fat	-	0.33 + 1.6	0.05 + 1.6	0.624
Total fat as %	44.5 + 7.3	43.0 + 9.6	43.7 + 9.1	0.873
Muscle as %	23.9 + 4.2	25.0 + 6.2	24.0 + 4.1	0.73
Circumference in cm
Umbilical	101.2 + 13.2	98.8 + 11.8	94.1 + 18.7	0.07
Hip	113.0 + 11.3	110.3 + 10.2	109.3 + 11.3	0.182
Waist	98.4 + 12.6	96.4 + 11.8	95.7 + 12.3	0.056
Waist-to-hip ratio	0.87 + 0.7	0.87 + 0.08	0.87 + 0.08	0.876
Elastography
kPa	6.9 + 2.3	6.5 + 2.8	5.9 + 3.1	0.132
∆kPa	-	-0.27 + 2.8	1.13 + 3.4	0.032

BMI: Body mass index; MD: Mediterranean diet.